Consider a bearish stance on the quantum computing sector, as insiders believe it is overvalued and poised for a further decline, with Rigetti (RGTI) showing particular weakness. Conversely, Sarepta Therapeutics (SRPT) is viewed as a compelling long-term investment that is "too good to ignore." Similarly, uniQure (QURE) is highlighted as a strong performer with continued positive sentiment despite its recent price increase. For a shorter-term trade, European biotech firm Abivax (ABVX.PA) is expected to reach a price of 90 in the near future. The overall strategy suggests avoiding speculative tech sectors while selectively investing in high-conviction biotechnology names.

Quantum Computing Sector

• The speaker reveals he has a massive short position on the quantum computing sector, meaning he is betting that the stock prices of companies in this sector will go down.
• This trade has been very successful for him, with his portfolio reportedly up 133% primarily due to this position.
• He describes the sector as "dead, at least for now" and believes that even after recent price drops, the companies are still "huge companies market cap wise," suggesting there is still "a lot of meat on the bones" for shorts (i.e., prices could fall further).
• He notes a "very weak rally" in some quantum names, which he sees as a sign of underlying weakness.

Takeaways

• The speaker holds a strong bearish view on the quantum computing sector, believing it is overvalued and poised for a further decline.
• He specifically warns listeners about his aggressive strategy, stating, "don't do what I do folks don't try this at home I'm a madman." This highlights the high-risk nature of shorting a volatile sector.
• Investors should be cautious with quantum computing stocks, as the speaker's sentiment suggests the recent hype may be fading, leading to potential price corrections.

Rigetti Computing (RGTI)

• The speaker points to Rigetti as a prime example of weakness in the quantum sector.
• He highlights a "very very concerning" signal where the stock failed to go up even after the company released "pretty good data."
• He states that when a stock doesn't rise on good news, it is a highly concerning sign for stockholders.

Takeaways

• The price action of RGTI is seen as a major red flag. A stock's inability to rally on positive news can indicate a lack of buyer interest and strong selling pressure, which is a bearish signal.
• This specific event reinforces the speaker's overall negative thesis on the quantum sector.

Sarepta Therapeutics (SRPT)

• The speaker mentions that he holds a position in Sarepta.
• He expresses a very positive sentiment, stating that the company is "just too much too good to ignore."

Takeaways

• The speaker is bullish on Sarepta (SRPT).
• His comment suggests he sees significant long-term value or a strong catalyst in the company that makes it a compelling investment, even if other parts of his portfolio are speculative.

uniQure N.V. (QURE)

• The speaker notes that uniQure was a "big win" for his portfolio.
• He states, "I like Cure. It's gone up a lot," indicating a continued positive outlook despite its recent run-up in price.

Takeaways

• The speaker is bullish on uniQure (QURE).
• This is another biotech name he favors, suggesting he sees strength in specific companies within the healthcare sector, separate from his macro bet against quantum computing.

Reddit (RDDT)

• The stock was "getting smoked" (trading down significantly) at the time of the podcast.
• The catalyst for the drop was a report from SimilarWeb suggesting that ChatGPT is slowing its use of Reddit data and not citing it as frequently.
• The speaker is personally skeptical that this news "matters that much," but acknowledges that for a stock like Reddit that has "been on such a run," any piece of negative news can trigger a sell-off.

Takeaways

• High-flying stocks that have experienced rapid price appreciation, like RDDT, can be extremely sensitive to negative news, regardless of its fundamental importance.
• This serves as a reminder of the sentiment-driven risk in recently IPO'd or "hot" stocks. A change in the narrative can cause sharp price drops.

Other Stock Mentions

• Abivax (ABVX.PA): The speaker mentions a potential price movement, stating, "I think Abivax hit 90 soon, more or less." This indicates a bullish short-term price expectation.
• AstraZeneca (AZN): The company is reportedly planning a direct U.S. listing in addition to its existing American Depositary Receipt (ADR). This could potentially increase trading volume and visibility for U.S. investors.
• Oklo (OKLO): The speaker uses Oklo as a bellwether for meme stocks, stating, "Looking at Oklo usually is the best way to tell what gonna happen" with that category of stocks.
• Nike (NKE): Mentioned positively in passing due to "good results."
• Lithium Americas (LAC): Noted as "trading up 31%" at the market open, indicating significant positive momentum on the day.
• Nvidia (NVDA), Opendoor (OPEN), Meta (META): Mentioned briefly as being down or up slightly with no further analysis provided.
• Netflix (NFLX): Mentioned as having "some controversy," but no details were given.